SDGR
Schrodinger, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$23.12
+2.30%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$22.85
From 52W high−29.08%
Volume1.43M
Market cap$1.73B
P/E (TTM)—
P/S (TTM)6.7x
Div yield—
Key dataOct 19, 2026
Open
$22.85
From 52W high
−29.08%
Volume
1.43M
Market cap
$1.73B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−30.9x
P/E (TTM)
—
RSI (14)
40.7
MomentumView details →
1D Return
+2.30%
YTD Return
+29.36%
SummaryUpdated Jun 1, 2026
Schrödinger, Inc. (NASDAQ:SDGR) is a computational platform company founded in 1990 and headquartered in New York, New York. The company went public in February 2020 and operates at the intersection of physics-based computational methods and drug discovery. Schrödinger has evolved from a software company serving the pharmaceutical industry into a dual-business model enterprise that both licenses its computational platform to external customers and develops its own proprietary drug candidates. The company serves biopharmaceutical companies, industrial firms, academic institutions, and government laboratories worldwide.
Similar companies
Latest newsMore news →
Schrödinger announced publication in Nature Co., Ltd. of joint research with The Trustees of Columbia University in The City of New York and the New York Structural Biology Center on the atomic-scale structure of lithium-ion battery electrolytes.5d agoInductive Bio launched Indy, an AI assistant for recurring medicinal chemistry tasks, and Beacon-2, a predictive model for designing compounds with lower estimated human doses.14d ago